Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lcr Regenerans for Prevention of Recurrent Vulvovaginal Candidiasis
NCT02251093Phase 3Completed
- Sponsor
- Probionova
- Start
- May 2014
- Primary completion
- Feb 2016
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 3 trial of lactobacillus rhamnosus Lcr35 in vulvovaginal candidiasis (VVC), sponsored by Probionova. Started May 2014; status: completed.
02
Drugs
lactobacillus rhamnosus Lcr35
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT02251093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251093.